chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Estimated due date:  Unknown - around 08/15/2021 - 1st OB appt on 01/12/2021 -  I started having a headache on Thursday and chills and I checked my temp and it was 100.1F I monitored it and it was slowly climbing up. It hit 100.4F and I went home and it was 100.8F around 5PM I took a gram of Tylenol and few hours later headache and fever resolved and I felt completed normal after that. Next day all was back to normal but my arms hurt a lot the next day.
vertigo; unable to even walk unassisted for a month and also in 2021.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A 57-year-old male patient received BNT162b2 (BNT162B2), on 28Dec2020 as dose 1, 0.3 ml single (Lot number: EJ1685, Expiration Date: 31Mar2021), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Flu vaccine (Prior Vaccinations (within 4 weeks): None, had a flu vaccine but it was at the end of Sep2020), administration date: Sep2020, for Immunization. The following information was reported: VERTIGO (non-serious) with onset 03Jan2021, outcome "recovered" (03Jan2021); GAIT INABILITY (non-serious) with onset 2021, outcome "unknown", described as "unable to even walk unassisted for a month and also in 2021". The event "vertigo" required emergency room visit.  Additional information: The report was not related to a study or programme. On 28Dec2020 he had his first vaccine and 6 days later on 03Jan2021 was when his health problems began and it was vertigo; he had to seek medical attention for that and it lasted for months and months and was actually unable to even walk unassisted for a month and also in 2021. Vertigo: actually was  resolved on 03Jan2021 and it has at this point completely resolved. The initial visit to the emergency room was for the vertigo on he went the next morning on 04Jan2021. After the emergency room visit he saw a neurologist for the symptoms. His life changed forever 6 days after the first vaccine.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300168804 Same product, patient, different AEs, different dose;US-PFIZER INC-202300168805 Same product, patient, different AEs, different dose;
Vaccine given at 1030 - patient developed tighting in throat, no swelling. 1050 Epi 0.3 cc given via epi pen. in right thigh, Benadryl 50 mg IM given in Left deltoid.  BP 150/98 pulse 100 Medical emergency called patients sent to ER with ER personal via wh/chair, husband followed.
I presented at ER with burning, throbbing right leg pains at upper calf and upper thigh area.  The ER doctor said it was not a blood clot, but was the beginning of Shingles on the back of my right thigh, buttock and downward just below the back of my knee.  I was prescribed Acyclovir, Hydrocode with Tylenol and suggested topical creams.  I was unable to find the Zostrix suggested so began with Caladryl and Terrasil cream as well as baking soda/water soaks a couple times  a day.  As of today, February 12, I still have leg pain, markings from the lesions and am unable to sleep more than a couple of hours a night without throbbing, burning pain especially at 2 lesion sites.  Now taking Tylenol alternating with Tramadol for the pain.
Woke up with hives between my thighs. Next day got a hive on my breast
Patient was given a dose of Pfizer Covid-19 Vaccine that expired 05/31/2022.
Suspected Vaccination failure; get them yearly in the same spot on my back on the side I got the shot on; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself or herself. The age at vaccination was not reported. The patient got Shingles vaccine and got shingles yearly in the same spot on his/her back and on the side of shot. The patient took vaccine as doctor had insisted. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. For 1st occurrence of shingles after receiving Shingles vaccine refer linked case US2021AMR170517, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR170517:Same reporter
This spontaneous report was received from a nurse and refers to unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) (lot # L040414, expiration date 13-APR-2017; lot # reported as L045678, expiration date 09-MAY-2017 (also reported as 19-MAY-2017); lot # reported as L046508, expiration date 17-MAY-2017; lot # L046509, expiration date 17-MAY-2017; lot # L045676, expiration date 09-MAY-2017) (dose and route of administration were not reported). Administered doses experienced the temperature excursion of 8 degrees Fahrenheit for 48 hours and 45 minutes (also reported as 8 degrees Fahrenheit for 876 minutes (14.6 hours)). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt to hospital from SNF; positive for COVID; low O2 level; pneumonia and sepsis, without septic shock; persistent A Fib; again tested positive for COVID in hospital; respiratory failure; placed on BiPAP; increase in LFTs; hypokalemia; anemia; stage 4 coccyx wound, PEG tube infection; given ABX and steroids; poor prognosis; fevers started; pt nonresponsive; CXR showed bilateral pneumonia; pt's condition worsened; transitioned to comfort care and pt passed away in the hospital
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL lot # reported as AK006960, expiration date 19-FEB-2017 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient's daughter called the pharmacy 2 days after administration of vaccine about adverse reaction. Patient started feeling unwell about 9 hours after administration having fever, hives and cough. Covid test was also administered to rule out infection (negative).  Patient is feeling well today.
patient stated they were hot and experience heart palpitations patient was given an ice pack (patient started feeling better and heart palpitations went away) patient was taken to hospital and received a steroid and epi-pen (patient is stable now)
This spontaneous report received from a registered nurse referred to a 8 year old patient of unknown gender. The patient's medical history, current conditions and concomitant medications were not reported. On 12-SEP-2016, the patient was vaccinated with M-M-R II (lot number: L036851), dose, frequency, expiry date were not reported) which was stored improperly. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1609USA014830: same reporter US-009507513-1609USA013814: same reporter US-009507513-1610USA004339: same reporter.
Pt experienced muscle aches, extreme sweating episodes, and weakness/pain in fingers/vaccination arm on day of vaccination. Approximately 4 hours later, went to MD for A.E. MD said wait 48 hours. Pt came in next day feeling 70% better.
had increased fever @ bedtime (unk degree);small amount of rash-APAP inAM;had rash over body;
Ten days after shot, my arm became swollen, broke out in a rash and is warm to the touch about the size of a silver dollar around the injection site.
Pain at injection site lasting for the last 5 months. Difficulty moving arm. Painful to touch/sleep on.
Arm pain at injection site; swollen lymph nodes in neck, and right armpit; deep pain in right armpit; muscle aches in neck and shoulders; migraine; dizziness/lightheadedness; nausea; vertigo; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Apr2021 11:30 (Batch/Lot number: EW0172) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "Bactrim allergy" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; VITAMIN D3. Vaccination history included: Bnt162b2 (product: COVID 19 brand: Pfizer, lot number: ER8727, lot unknown: False, administration time: 11:00 AM, dose number: 1, vaccine location: Right arm, adverse event start date: 28Mar2021), administration date: 28Mar2021, when the patient was 44 years old, for Covid-19 immunization, reaction(s): "Arm discomfort". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "Arm pain at injection site"; LYMPHADENOPATHY (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "swollen lymph nodes in neck, and right armpit"; AXILLARY PAIN (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "deep pain in right armpit"; MYALGIA (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "muscle aches in neck and shoulders"; MIGRAINE (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "migraine"; DIZZINESS (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "dizziness/lightheadedness"; NAUSEA (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "nausea"; VERTIGO (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "vertigo"; FATIGUE (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "fatigue". The event "arm pain at injection site" was evaluated at the physician office visit. Therapeutic measures were taken as a result of vaccination site pain, lymphadenopathy, axillary pain, myalgia, migraine, dizziness, nausea, vertigo, fatigue.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID post vaccination. Since the vaccination, the was not tested. for COVID-19. Patient received treatment for the adverse event with Antibiotic, vestibular physical therapy. Patient received vaccine at facility type vaccine: Pharmacy or Drug Store. Other medications in two weeks include, Multivitamin  No follow-up attempts are possible. No further information is expected.
pt recvd vax 24MAY94 & states that evening felt some arthritic pain in fingers; this cont until 27MAY94 when fingers swelled to the point couldn't bend them & ha signifcant pain; went to ER on 28MAY94 states it was considered an allerg;
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Pt had itch, swelling and rash from injection site to forearm. Parents have given ibuprofen, benadryl and claritin. Pediatrician has referred pt to an allergist and told parents not to give her any more flu shots until her allergies are determined.
After receiving the vaccine that patient began to feel light headed and passed out. She said that she had never passed out after a vaccine previously but had passed out before due to unknown cause. The patient also stated that she had not ate anything yet today. She then passed out a second time.
Progress Notes Expand AllCollapse All      Patient:                                                                                                DOB:  4/11/1980  Date:  3/16/2021                                                                                           MRN:       Subjective Patient is a 40 y.o. female who was seen at  COVID Vaccine Clinic today for her second  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience generalized weakness, "need for a quick snack".  She denied rash, shortness of breath, difficulty swallowing or syncope   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to red flag findings         ALLERGY REVIEW OF SYSTEMS   Previous Reactions: none    Objective    Vitals Vitals:   03/16/21 0944 BP: (!) 158/103 Pulse: (!) 102 SpO2: 100%            Physical Exam Constitutional:      General: She is not in acute distress.    Appearance: She is not ill-appearing or diaphoretic.     Comments: Anxious on arrival to bay, "I think I just need a snack to feel better."  HENT:     Head: Normocephalic.     Mouth/Throat:     Mouth: Mucous membranes are moist.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.  Pulmonary:     Effort: Pulmonary effort is normal.  Musculoskeletal:        General: Normal range of motion.  Skin:    General: Skin is warm and dry.  Neurological:     Mental Status: She is alert.     Motor: No weakness.  Psychiatric:     Comments: Anxious affect    Clinically, post injection anxiety related event. Elevated BP on arrival, improved with rest and granola bar. Salient anxious affect, post injection histamine response, requiring warm blanket, prolonged rest Ambulated with assist, additional snacks provided and pt discharged after 45" stay    Assessment/Plan  Treatment included: snacks Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health)
Case number PHEH2015US003133 is an initial spontaneous report received from a nurse on 10 Feb 2015. This report refers to an 18 years old patient whose gender was not reported. The patient's medical history and concomitant medications were not reported. On 14 Jan 2015, MENVEO (batch number: M14071, expiry date: Nov 2015) was at 0.4 degree Celsius for 1 hour and 16 minutes and the patient received 0.5 ml intramuscular dose of this frozen vaccine with excursion on 19 Jan 2015. The vaccine had two more other excursion as follows: On 26 Jan 2015, the vaccine was at 0.8 degree Celsius for 36 minutes and on 31 Jan 2015 the vaccine was at 0.6 degree Celsius for 35 minutes. No adverse events were reported following the maladministration.
Patient had feeling of fatigue immediately after administration. Heart rate began elevating approximately 20:00 on 7/31/2023 on the same day of administration. Patient began having shortness of breath and dyspnea and was brought to emergency room via ambulance. Patient was treated with IV Benadryl, Solumedrol, Pepcid, Lorazepam and Duo-neb respiratory treatment. Magnesium and potassium levels dropped requiring replacement of PO potassium.
pink dermatitis at the injection site; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) and VACCINATION SITE PAIN (soreness at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 042B21A,) for COVID-19 vaccination.     The patient's past medical history included Headaches cluster (Unknown origin for 20 years). Concurrent medical conditions included Dermatitis (Prone to rashes and has very sensitive skin) and Spinal stenosis (Steroid shots every 6 months). Concomitant products included PARACETAMOL (TYLENOL) for Headache.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) and VACCINATION SITE PAIN (soreness at the injection site). On 12-May-2021, VACCINATION SITE PAIN (soreness at the injection site) had resolved. At the time of the report, VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) was resolving. Not Provided          The patient was prescribed a steroid cream (unknown name, strength, and dose) from their health care provider for the pink dermatitis.
Rash on left breast, axilla, and back started 2 weeks post-vaccine. Started with burning pain of left breast. Then developed rash on upper left breast. Then noted rash in left axilla and some areas on left upper back. No itching. Painful. No discharge. Feels tired and not herself. No fevers or headaches. PCP diagnosed patient with herpes zoster.
Pain redness and swelling at injection site.  Redness about the size of a baseball.  Pain and swelling went away on day 4  On Day 6 swelling and redness came back with itchy sensation, area the size of a baseball.  Redness and swelling continued to grow and still exists at day 9. It is now the size of my hand, fingertips to my wrist.  Taking benedryl and using hydrocortisone cream.  Redness is fading on the inside of the area, but continuing to spread on the outer edges.   I have concerns about getting the second shot.  I am due to get it Jan 28
This spontaneous report was received from a nurse concerning a 12 years old patient of unknown gender. There was no information about the patient's medical history, concurrent conditions and concomitant therapies. On 17-JAN-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot number M024261 with expiration date of 30-JUL-2018 (strength, anatomical location and route of administration were not provided) for prophylaxis. The administered dose was exposed to a temperature higher than 8°C but lower than 25°C for 1 hour and 20 minutes determined using digital data logger. The vaccine had no previous temperature excursion. The nurse reported that a possible cause for the temperature excursions was the action of the auto defrost cycle of the refrigerator. They had ordered a commercial unit to eliminate this issue. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008111: Original Case: 1701USA008111.
Approx 4.5 to several hours after vaccine given patient developed fever to 102 F and had 3 brief GTC seizures.
discomfort; notices an ache at about a 1 to 1.5 inch radius of where the shot was given/On a scale of 1-10 it is a 1/got the shot it hurt/Ache in right arm; This is a spontaneous report from a contactable consumer via Medical information team. A 72-year-old male patient received pneumococcal 13- valent conjugated vaccine (diphteria crm197 protein) (PREVNAR 13), via an unspecified route of administration on Jan2020 at single dose for pneumonia prevention and immunization. Medical history included mild case of Crohn's disease from an unknown date and unknown if ongoing. Concomitant medication included low dose iron supplementation, mesalazine (LIALDA) and a mild dose of pravastatin. It was reported that the patient received PREVNAR 13 injection 3 months ago, and is still experiencing ache in right arm. It took him years to get the nerve to get it. The patient was asking when should he expect discomfort to resolve and any recommendations on managing/treating. The healthcare professional was unaware of post injection experience. The patient still notices an ache at about a 1 to 1.5 inch radius of where the shot was given. On a scale of 1-10 it is a 1. It is more of an annoyance. He notices it when he lifts his arm. When the patient got the shot it hurt like a normal shot would. He put an ice pack on his arm prior to the shot, and then put an ice pack back on his arm to alleviate the pain. It wasn't much more pain than a flu shot. The outcome of the event "notices an ache at about a 1 to 1.5 inch radius of where the shot was given/on a scale of 1-10 it is a 1/got the shot it hurt/ache in right arm" was not recovered while unknown for the other event.  No follow-up attempts are needed. No further information is expected.
This initial spontaneous report was received from a healthcare professional as part of a marketing research program conducted by HRA, referring to an unknown number of young children of unknown ages and genders. The patient's concurrent conditions, concomitant medication or medical history were not provided. The reporter stated that on unspecified dates the patient were vaccinated with PNEUMOVAX 23 injection (dose, route, lot# and expiration dates were not provided) but according to what he/she heard about the new "ACIP" recommendation regarding pneumococcal vaccines, it did not work and did not provide long-term protection. At the time of the report, the outcome of the event was unknown. Additional information has been requested.
This spontaneous report was received from a pharmacist regarding an unknown number of patients of unknown age and gender. On an unknown date, the pharmacist reported that an unknown number of doses of PNEUMOVAX23 (lot# and expiry not reported) were exposed to 70 degrees Fahrenheit(F) for a 2 week period may have been administered. No adverse effect was reported. It was unspecified if the patients had sought medical attention. Additional information has been requested.
Two days after the vaccine I started getting a ringing in my ear- Pulsatile Tinnitus. High pitched whooshing sounds to the beat of my heart. Since I had a  sinus cold earlier in the month, I started taking over the counter medication - Flonaise, Tylenol Cold & Sinus, and Mucenix. When those didn't work I was referred to a ENT doctor, where I was prescribed doxycycline, budesonide. After that, a CT sinus SCAN, nasal scope, MRA MRI Angiogram cerebral, and MRI brain scan w w/o contrast. Now 4 months later, we still haven't found the reason for the tinnitus. Tomorrow I am scheduled for a CT Angiogram CTA neck.
Initial report received from a health care professional (nurse) on 06 Jul 2010: This patient inadvertently received a 0.5ml intramuscular dose of the liquid component of MENVEO (batch no (box): 100005) instead of being reconstituted with the lyophilized component. No adverse effects were noted following this administration.
Pain at injection site as well as swelling, heat, and hardness.  Headache accompanied with pain in the neck. All pain has subsided as of today.  Injection site is still hot, red, and hard.
6 hours after immunizations had increased swelling R shoulder to elbow, 12 hours later skin turned bright red, developed pupules and vesicles and itching.  Also had myalgias, fever, cough, chills.  Developed the lesion in area where shots had been given.  Will have patch testing to preservatives in vaccines themselves.